Phoebe Rich

Summary

Publications

  1. ncbi request reprint Diagnosis, clinical implications, and complications of onychomycosis
    Phoebe Rich
    Oregon Health Science University, Portland, OR, USA
    Semin Cutan Med Surg 32:S5-8. 2013
  2. ncbi request reprint Topical treatment of onychomycosis with efinaconazole solution 10%
    Phoebe Rich
    Department of Dermatology, Oregon Health and Science University, Portland, USA
    Cutis 91:305-7. 2013
  3. ncbi request reprint Treatment of uncomplicated skin and skin structure infections in the diabetic patient
    Phoebe Rich
    J Drugs Dermatol 4:s26-9. 2005
  4. ncbi request reprint Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
    Phoebe Rich
    Oregon Health Sciences University, Dermatology and Clinical Research, Portland, Oregon 97210, USA
    J Am Acad Dermatol 58:224-31. 2008
  5. ncbi request reprint Dermatophyte test medium culture for evaluating toenail infections in patients with diabetes
    Phoebe Rich
    Department of Dermatology, Oregon Health Sciences University, Portland 97210, USA
    Diabetes Care 26:1480-4. 2003
  6. ncbi request reprint Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis
    Phoebe Rich
    Oregon Health Sciences University, Portland, OR 97210, USA
    J Am Acad Dermatol 49:206-12. 2003
  7. ncbi request reprint Nail cosmetics
    Phoebe Rich
    Oregon Health and Sciences University, 2565 NW Lovejoy Street, Portland, OR 97210, USA
    Dermatol Clin 24:393-9. 2006
  8. ncbi request reprint Onchomycosis: an overview
    Boni E Elewski
    Department of Dermatology, University of Alabama Birmingham, AL, USA
    J Drugs Dermatol 12:s96-103. 2013
  9. ncbi request reprint Promoting and maintaining or restoring healthy nails: practical recommendations for clinicians and patients
    David Pariser
    Eastern Virginia Medical School, Department of Dermatology, Pariser Dermatology, 601 Medical Tower, Norfolk, VA 23507, USA
    Semin Cutan Med Surg 32:S13-4. 2013
  10. ncbi request reprint Current and emerging options in the treatment of onychomycosis
    Boni Elewski
    Department of Dermatology, University of Alabama School of Medicine, Birmingham, AL 35294 0009, USA
    Semin Cutan Med Surg 32:S9-12. 2013

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Diagnosis, clinical implications, and complications of onychomycosis
    Phoebe Rich
    Oregon Health Science University, Portland, OR, USA
    Semin Cutan Med Surg 32:S5-8. 2013
    ....
  2. ncbi request reprint Topical treatment of onychomycosis with efinaconazole solution 10%
    Phoebe Rich
    Department of Dermatology, Oregon Health and Science University, Portland, USA
    Cutis 91:305-7. 2013
    ..This case demonstrates for physicians that efinaconazole solution 10% is a promising new topical treatment of onychomycosis and emphasizes the importance of mycologic cure as an early indicator of treatment success. ..
  3. ncbi request reprint Treatment of uncomplicated skin and skin structure infections in the diabetic patient
    Phoebe Rich
    J Drugs Dermatol 4:s26-9. 2005
    ..Culture samples must be taken by curettage of biopsy rather than by swabbing to assure detection of pathogens...
  4. ncbi request reprint Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
    Phoebe Rich
    Oregon Health Sciences University, Dermatology and Clinical Research, Portland, Oregon 97210, USA
    J Am Acad Dermatol 58:224-31. 2008
    ..Although nail psoriasis occurs frequently in patients with psoriatic skin lesions, effective treatments are limited...
  5. ncbi request reprint Dermatophyte test medium culture for evaluating toenail infections in patients with diabetes
    Phoebe Rich
    Department of Dermatology, Oregon Health Sciences University, Portland 97210, USA
    Diabetes Care 26:1480-4. 2003
    ..To evaluate the performance of the in-office dermatophyte test medium (DTM) culture when used to confirm the diagnosis of onychomycosis in diabetic patients...
  6. ncbi request reprint Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis
    Phoebe Rich
    Oregon Health Sciences University, Portland, OR 97210, USA
    J Am Acad Dermatol 49:206-12. 2003
    ..The NAPSI will be useful during clinical trials for evaluating response to treatment of psoriatic nails. The scale is reproducible, and because there are few data points, statistical analysis is simplified...
  7. ncbi request reprint Nail cosmetics
    Phoebe Rich
    Oregon Health and Sciences University, 2565 NW Lovejoy Street, Portland, OR 97210, USA
    Dermatol Clin 24:393-9. 2006
    ..The grooming and decoration of nails is a well-ingrained cultural ritual in many countries of the world. In the United States alone, US dollars 6.4 billion was spent on nail salon services in the year 2004...
  8. ncbi request reprint Onchomycosis: an overview
    Boni E Elewski
    Department of Dermatology, University of Alabama Birmingham, AL, USA
    J Drugs Dermatol 12:s96-103. 2013
    ..Hyperkeratosis occurs under the nail plate, resulting in detachment of the nail plate from the nail bed (onycholysis), with subungual thickening...
  9. ncbi request reprint Promoting and maintaining or restoring healthy nails: practical recommendations for clinicians and patients
    David Pariser
    Eastern Virginia Medical School, Department of Dermatology, Pariser Dermatology, 601 Medical Tower, Norfolk, VA 23507, USA
    Semin Cutan Med Surg 32:S13-4. 2013
    ..This article provides a quick reference for clinicians and includes a handout for patients to support the health care provider's educational efforts...
  10. ncbi request reprint Current and emerging options in the treatment of onychomycosis
    Boni Elewski
    Department of Dermatology, University of Alabama School of Medicine, Birmingham, AL 35294 0009, USA
    Semin Cutan Med Surg 32:S9-12. 2013
    ..Recurrence of infection is common; the risk for recurrence may be reduced by adherence to preventive measures, especially avoiding (if possible) or promptly treating tinea pedis infections...
  11. doi request reprint Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies
    Boni E Elewski
    Department of Dermatology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294 0009, USA
    J Am Acad Dermatol 68:600-8. 2013
    ..Topical lacquer treatments have negligible efficacy. Oral treatments, although more efficacious, are limited by drug interactions and potential hepatotoxicity...
  12. doi request reprint A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index
    Caitlin Carney
    Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Arch Dermatol 147:1277-82. 2011
    ..Mild onychomycosis corresponds to a score of 1 through 5; moderate, 6 through 15; and severe, 16 through 35...
  13. ncbi request reprint Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma
    Helen Mary Torok
    HMT Dermatology Associates, Inc, Medina, Ohio, USA
    Cutis 75:57-62. 2005
    ..In this study, a once-daily application of TC cream over an extended period of 12 months showed no notable safety concerns and offered an effective treatment for melasma...
  14. ncbi request reprint Modern methods to treat superficial fungal disease
    James Q Del Rosso
    Department of Dermatology, University of Alabama at Birmingham, USA
    Cutis 79:6-29. 2007
  15. ncbi request reprint Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting
    April W Armstrong
    Department of Dermatology, University of California Davis, Sacramento, California 95816, USA
    J Rheumatol 40:1438-41. 2013
    ..Finally, GRAPPA members discussed autoimmune comorbidities associated with psoriasis and PsA; they agreed that research is nascent in this field and larger studies are necessary to determine the precise magnitude of these associations. ..
  16. ncbi request reprint Treating cosmetically induced nail problems
    Renee McLean Chang
    Oregon Health and Science University, Department of Dermatology, Portland, Oregon 97239, USA
    Dermatol Ther 20:54-9. 2007
    ..In spite of efforts to that end, nail salon procedures and materials can cause nail disease that must be recognized and treated in order to restore the nails to health...
  17. ncbi request reprint Efficacy and safety of a new triple-combination agent for the treatment of facial melasma
    Susan C Taylor
    Dermatology Associates, St Luke s Roosevelt Hospital, New York, New York 10025, USA
    Cutis 72:67-72. 2003
    ..The most common adverse reactions seen with all treatment groups were erythema, skin peeling, burning, and/or stinging sensation. The majority of treatment-related adverse events were of mild severity...
  18. ncbi request reprint Improving outcomes through collaboration
    Diane M Thiboutot
    Pennsylvania State University College of Medicine, Hershey, USA
    Cutis 81:26-31. 2008
    ..Female patients should be advised to see their gynecologists annually for breast and pelvic examinations and to discuss their concerns surrounding the use of OCs...
  19. ncbi request reprint The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis
    Sarah E Cassell
    Division of Rheumatology, Allergy and Immunology, University of California, San Diego, San Diego, California, USA
    J Rheumatol 34:123-9. 2007
    ..Beginning with NAPSI, our goal was to validate a psoriatic nail assessment tool for use in clinical trials, and investigate correlations between nail and other PsA features...
  20. ncbi request reprint Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study
    John K Geisse
    Solano Dermatology Associates, Vallejo, California 94589, USA
    J Am Acad Dermatol 47:390-8. 2002
    ..Imiquimod 5% cream may provide an effective nonsurgical treatment for superficial basal cell carcinoma (sBCC) based on results of previous studies...
  21. ncbi request reprint A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris
    Diane Thiboutot
    Pennsylvania State University College of Medicine, Hershey, USA
    Clin Ther 24:773-85. 2002
    ..Topical erythromycin/benzoyl peroxide (EBP), marketed for acne treatment, must be compounded by a pharmacist and requires subsequent refrigeration, warranting the development of alternate formulations...